Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Cincinnati, OH
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Oklahoma City, OK
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Medford, OR
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Medford, OR
Click here to add this to my saved trials
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
West Reading, PA
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
West Reading, PA
Click here to add this to my saved trials
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Chattanooga, TN
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Arlington, TX
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Arlington, TX
Click here to add this to my saved trials
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Austin, TX
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Dallas, TX
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Houstan, TX
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Houstan, TX
Click here to add this to my saved trials
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
San Antonio, TX
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
St. Poelten,
Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
St. Poelten,
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Birmingham, AL
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Mobile, AL
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Mobile, AL
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Chandler, AZ
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Chandler, AZ
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Glendale, AZ
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Glendale, AZ
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Goodyear, AZ
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Goodyear, AZ
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Mesa, AZ
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Mesa, AZ
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Phoenix, AZ
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Tucson, AZ
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Fountain Valley, CA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Garden Grove, CA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Glendale, CA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Glendale, CA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Long Beach, CA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Los Angeles, CA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Oceansside, CA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Oceansside, CA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Sacramento, CA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Santa Ana, CA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Upland, CA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Upland, CA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Colorado Springs, CO
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Boynton Beach, FL
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Brandon, FL
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Brandon, FL
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Brooksville, FL
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Brooksville, FL
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Clearwater, FL
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Fort Meyers, FL
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Fort Meyers, FL
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Jacksonville, FL
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Lake City, FL
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Lake City, FL
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Lakeland, FL
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Lakeland, FL
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Orlando, FL
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Orlando, FL
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
South Miami, FL
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
South Miami, FL
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
St. Petersburg, FL
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Tampa, FL
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Atlanta, GA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Blue Ridge, GA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Blue Ridge, GA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Decatur, GA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Decatur, GA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Savannah, GA
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Savannah, GA
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Boise, ID
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Boise, ID
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Aurora, IL
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Aurora, IL
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Bloomington, IL
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Bloomington, IL
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Decatur, IL
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Decatur, IL
Click here to add this to my saved trials
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated:  11/13/2015
Shionogi Research Site
mi
from
Rockford, IL
Long Term Safety of Naldemedine
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 11/13/2015
Shionogi Research Site
mi
from
Rockford, IL
Click here to add this to my saved trials